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Abstract
In this observational study the outcomes of an EEG-based infra-low-frequency 
(ILF) neurofeedback intervention on patients with attention deficit (hyperactiv-
ity) disorder (ADHD) are presented. The question is addressed whether this 
computer-aided treatment, which uses a brain-computer-interface to alleviate the 
clinical symptoms of mental disorders, is an effective non-pharmaceutical therapy 
for ADHD in childhood and adolescence. In a period of about 15 weeks 196 ADHD 
patients were treated with about 30 sessions of ILF neurofeedback in an ambulant 
setting. Besides regular evaluation of the severity of clinical symptoms, a continu-
ous performance test (CPT) for parameters of attention and impulse control was 
conducted before and after the neurofeedback treatment. During and after the 
therapy, the patients did not only experience a substantial reduction in the severity 
of their ADHD-typical clinical symptoms, but also their performance in a continu-
ous test procedure was significantly improved for all examined parameters of atten-
tion and impulse control, like response time, variability of reaction time, omission 
errors and commission errors. In a post neurofeedback intervention assessment 
97% of patients reported improvement in symptoms of inattention, hyperactivity 
or impulsivity. Only 3% of the patients claimed no noticeable alleviation of ADHD-
related symptoms. These results suggest that ILF neurofeedback is a clinically 
effective method that can be considered as a treatment option for ADHD and might 
help reducing or even avoiding psychotropic medication.
Keywords: Infra-low frequency (ILF) neurofeedback, ADHD, therapy,  
continuous performance test, clinical study
1. Introduction
Hyperkinetic disorder, also known as attention deficit disorder (ADD) or atten-
tion deficit hyperactivity disorder, is a disorder that typically occurs in childhood. 
The core symptoms include increased inattention and/or hyperactivity and impul-
sivity as well as lack of emotional self-control and motivation. ADHD is a complex 
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psychiatric and neurologically based disorder that usually is comorbid with other 
conditions: over one-half of children with ADHD have accessory symptoms like 
learning disabilities, conduct disorders, poor coordination, depression, anxiety, 
obsessive–compulsive disorders and bipolar disorders [1, 2]. Accordingly, the 
pathophysiological causes of ADHD are to be found in the central nervous system 
(CNS). Corresponding studies on ADHD patients show changes in dopaminergic 
and noradrenergic neurotransmission [3–6] as well as a (presumably related) 
developmental delay of the cortex, especially in the prefrontal region relevant for 
executive functions, attention and motor control [7]. In addition to these functional 
changes in defined brain areas, functional imaging studies in ADHD patients also 
have demonstrated changes in neuronal networks, e.g., in frontostriatal, fronto-
parietal and ventral attention networks [8, 9] and in the default mode network 
(DMN) [10].
According to current estimations about five percent of children worldwide meet 
the diagnostic criteria of ADHD [11] and if left untreated, symptoms may persist 
into adulthood. Therefore, innovative and effective treatment methods that show 
long-lasting effectivity without the accompanying unwanted side effects of psycho-
tropic drugs are of great relevance. Neurofeedback has been proven to be a treat-
ment method that offers comparable effects in the therapy of ADHD like the use 
of pharmacological substances such as methylphenidate [12–17]. Follow-up studies 
and meta-analyses six, 12 or even 24 months after neurofeedback treatment show a 
sustained improvement of ADHD core symptoms [18, 19].
Neurofeedback is a computer-aided therapy method for clinical use, mainly as a 
treatment for mental disorders with the aim to improve self-regulation processes of the 
brain using a brain-computer interface (BCI). During a neurofeedback session selected 
parameters of the patient’s electroencephalogram (EEG) are extracted according to 
their frequency and power density, processed, transformed into audio-visual feedback 
signals which then are being made perceptible for the patient’s sensory organs by 
computer animations. By utilizing specific frequency components of the continuously 
measured full band EEG, the corresponding cerebral activities and their dynamics are 
reported back (feedback) to the central nervous system from where they originate. 
Due to the high performance of today’s modern EEG and computer systems, electrical 
potential fluctuations of cerebral origin can continously be recorded from the skull 
with a high dynamic range. Furthermore, the neurofeedback-specific processing up 
to the generation and visual and acoustic presentation of the feedback signals can take 
place almost in real time, so that there is a minimal time delay only between the brain’s 
generation of electrical activity, its electroencephalographical measurement and the 
presentation and perception of the EEG-derived audio-visual feedback signals. As a 
result, the brain can interact with the perceptual audio-visual “echo” of parts of its own 
activity, by improvement of its self-regulatory abilities [20, 21].
It has been known for a long time that brain functions can be influenced by 
feedback mechanisms [22], but neurofeedback was only developed in the late 
1960s – without its clinical potential being recognized at first. A few years later, the 
first clinical studies showed particularly good therapeutic success using this tech-
nique in patients with severe epilepsy [23–26]. It was later shown that the effects 
remained even ten years after the end of the neurofeedback treatment [27]. Since 
self-regulation is an essential and fundamental function of the brain, the clinical 
treatment spectrum of neurofeedback is broad. Thus, in addition to epilepsy and 
the already mentioned hyperkinetic disorder, neurofeedback has also been shown 
to be an appropriate treatment for many other neurological disorders involving 
brain dysregulation, such as autism spectrum disorder (ASD) [28–33], migraine 
[34, 35], post-traumatic stress disorder (PTSD) [36–40], schizophrenia [20] and 
several others.
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The various neurofeedback methods used typically differ in the extraction of the 
frequency components of the measured EEG that are used to calculate and control 
the feedback signals. In so-called frequency band training, the focus is on conven-
tional frequency ranges of the human EEG between 1 and 40 Hz. Brain activities in 
this range usually dominate the EEG due to their clearly visible wave-like characters. 
It has long been confirmed in clinical studies that neurofeedback training in these 
frequency ranges, namely 4–8 Hz (theta range), 12–15 Hz (sensorimotor rhythm, 
SMR), and 16–20 Hz (beta range), can be an appropriate and effective treatment 
for children with ADHD [40–42]. However, the full band EEG also contains long-
lasting potential shifts that are assigned to slow activities of the frequency range 
below 0.1 Hz. Such potential fluctuations typically are created by cortical neurons 
in preparation for sensomotoric tasks as well as for motor or cognitive behavior and 
events [16, 43]. According to their functional significance, these voltage signals are 
either classified as readiness potentials or, according to their time course, referred as 
slow cortical potentials (SCPs). It is assumed that slow surface negative potentials 
of cortical neurons represent a measure for the excitability of cortical neurons, 
while positive defections of such SCPs in the EEG signify a widespread absence of 
facilitation [43–45]. By influencing SCPs with weak external direct current voltage 
stimuli applied to the head, it could be shown that slow cortical negativity in certain 
cortical areas leads to better performance in sensorimotor tasks [16]. Abnormalities 
in SCP size seem to affect behavior and it has, for instance, been shown that chil-
dren with ADHD show EEG abnormalities in the frequency range of SCPs [46, 47]. 
Children with attention deficits show smaller negative SCPs during the anticipation 
phase of a task in comparison to children without attention problems [16]. The two 
neurofeedback training methods that utilize such slow potentials in the EEG are 
ILF- and SCP-neurofeedback. Various studies document SCP neurofeedback train-
ing as an effective form of therapy for ADHD [18, 48, 49].
ILF neurofeedback was primarily developed empirically based on clinical obser-
vations from the frequency band and SCP methods. It utilizes the conventional fre-
quencies between 1 and 40 Hz within nine fixed bands and transforms any dynamic 
progression of their spectral power above individual thresholds into a certain set of 
feedback signals (“Inhibits”). By this mechanism, the brain receives feedback about 
sudden changes in spectral power densities, which are linked directly to the respec-
tive brain activity components in the EEG. At the same time, the amplitudes and 
dynamics of the very slow cortical potentials of the “infra-low” frequency range 
of <0.1 Hz are determined in the EEG and, after setting an individual gain factor 
via a lowpass filter cutoff frequency by the therapist, transferred as a second set of 
feedback signals (“Signal”). The ILF neurofeedback protocol determines that the 
EEG is recorded in a bipolar montage. Thus, not the dynamically changing brain 
activity underneath each two electrodes is the targeted signal but their ratio and 
consequently, ILF neurofeedback represents a coherence training.
Other essential and standalone elements of the ILF neurofeedback protocol are 
that neither specific frequencies of brain activity in the EEG are actively promoted 
or suppressed via the feedback process, nor is the patient supposed to produce brain 
activity of specific frequencies voluntarily. Rather, the therapeutic work in ILF 
neurofeedback is based on the assumption that the symptoms of the patient indicate 
over- or under-excitation in certain multiple association areas of the brain [50]. By 
placing the EEG electrodes above such multiple association areas on the head of the 
patient, the brain receives continuous feedback on its internal states. This happens 
via up to 15 different computer-generated audio-visual feedback signal parameters 
to trigger neurophysiological modulation on an unconscious level.
The patient may become aware of the feedback-induced cerebral changes 
through the conscious perception of temporary positive sensations, like relaxation, 
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increased concentration or motoric calmness or a reduced level of alertness. 
However, such temporary sensations could also be mild sensations of fatigue, 
headaches, increased motor activity or dizziness and thus, unwanted effects. The 
therapist is therefore encouraged, to always observe the patient for signs of relax-
ation, stress, comfort or discomfort and to also inquire at regular intervals about 
perceived feelings. In case of positive observations or reports from the patient the 
therapist will proceed with the actual settings of the training parameters or change 
them to eliminate unwanted effects.
In addition to these partly subjective effects of the training, there were recently 
also reports published that demonstrate defined neurophysiological changes in the 
brain which can be attributed to the use of ILF neurofeedback. A quantitative analy-
sis of 19-channel EEG recordings before and after 20 sessions of ILF neurofeedback 
training shows a significant increase in spectral power in the 0.5 Hz frequency band 
[51, 52]. The general increase in spectral power of the ILF component of the EEG 
indicates that ILF neurofeedback training induces a modified baseline brain state. 
Another study using functional magnetic resonance imaging (fMRI) shows that 
even a single session of ILF neurofeedback leads to significant changes in connectiv-
ity in the brain [53].
While SCP and frequency band training have been used for many years to treat 
ADHD, there are only a few studies in which ILF neurofeedback has been used as a 
treatment method [54]. ILF neurofeedback could represent a particularly effective 
treatment method for pathologies in which the brain is dysregulated. It combines 
the above-mentioned components that characterize the procedure with the meth-
odological immanence for the therapist to adapt the treatment to the patient’s 
individual symptomatology. In consequence, the natural question arises concerning 
the evidence-based level of ILF neurofeedback therapy. The present study therefore 
aims to clarify the question whether ILF neurofeedback is an effective therapy for 
children and adolescents with ADHD. In addition, little research has been done on 
the effectiveness of neurofeedback for ADHD in everyday life, so the present study 
tracks the individual symptom profiles. This examines if the effect of ILF neuro-
feedback leads to an improvement in life quality of those affected.
2. Methods
2.1 Study operator and therapists
The present study was conducted as a pilot project of a network of five practices 
for child and adolescent psychiatry in Germany. It is in accordance with the declara-
tion of Helsinki. All interventions mentioned in this study were carried out by a 
total of 25 specialist therapists who had qualified in a certified training course of 
ILF neurofeedback lasting several days.
The data of the present observational study was collected by the participating 
practices in the course of treatment of their patients. A declaration of consent for 
the anonymized collection and processing of the data in the sense of an observa-
tional study with a pilot character was enclosed with the treatment contract, which 
the patients received before the start of the therapy, and which was signed by the 
patients or, in the case of minors, by the parents.
2.2 Participants
Participants in this study were recruited from children and adolescents who 
visited one of the participating practices due to ADHD-related symptoms or already 
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diagnosed ADHD. Some of them were already under drug treatment with methyl-
phenidate medication at the beginning of the study. In addition to age and informed 
consent, the clinically validated diagnosis of attention deficit (hyperactivity) 
disorder was another inclusion criterion for study participation. Figure 1 shows the 
inclusion criteria for the study.
A total of 251 patients participated in the data collection and received therapy 
in the form of ILF neurofeedback treatment. On average, these patients had an 
age of 12.1 years (SD: 2.8, interval: 7.3–21.5), with 82% belonging to the age group 
7–14 years and 18% to the age group 15–21 years. The gender distribution of the 
participants shows a majority of 79% males and 21% females.
2.3 Study design
In the present observational study, a symptom tracking procedure was used to 
measure subjectively perceived expression and severity of ADHD-typical symp-
toms before the start (T0) and at the end (T2) of ILF neurofeedback therapy. A 
QIKtest device was used for continuous performance tests to measure for attention, 
sustained attention, and impulse control at T0 and T2. For each participant the 
therapy consisted of approximately 30 ILF neurofeedback sessions, each lasting up 
to 50 minutes, with about two sessions every week and thus, a therapy period of 
about 15 weeks (see Figure 2).
2.4 Electrophysiology and software
The ILF neurofeedback interventions were performed with neurofeedback 
systems from BEE Medic Inc. (Germany), that consist of a 2-channel EEG differen-
tial amplifier EEG NeuroAmp® II (Corscience Inc., Germany) with full bandwidth 
(DC to 100 Hz), 32 bit resolution, a sampling rate of 500 sps and integrated imped-
ance meter (impedance range 0–140 kOhm) as well as the software Cygnet® (BEE 
Medic Inc., Germany).
Figure 1. 
Inclusion and exclusion criteria of this observational study. Included into the study were children and 




Before applying the electrodes, the skin at the electrode positions was treated 
with an abrasive cleaning paste (Nuprep®, Weaver and Company, USA) and then 
Ag/AgCl electrodes were applied using conductive paste (Ten20®; Weaver and 
Company, USA) to ensure a proper conductivity.
2.5 ILF neurofeedback protocol
The used neurofeedback-method was according to the ILF neurofeedback 
protocol and followed the description of Susan Othmer [55]. It consists of a 2-chan-
nel EEG that was recorded from the scalp of a patient using a bipolar montage and 
electrode placement sites in accordance with the international 10–20 EEG system. 
Electrodes were placed individually according to the protocol guide [55], with start-
ing placements at T3-T4 or T4-P4 electrode sites.
The neurofeedback process and the audio visual feedback was controlled and 
applied using Cygnet® software. During continuous EEG recording, features of the 
EEG were extracted in near real time to build two different dynamically changing 
components of the feedback process: “Inhibits” and “Signal”.
To calculate the “Inhibits” component, the supra-threshold EEG power densi-
ties of nine filter blocks in fixed frequency steps in the range between 1 and 40 Hz 
were summed up. The thresholds of the nine frequency bands were individually 
and dynamically set and adjusted to maintain the actual EEG power density of a 
frequency band to be sub-threshold for about 95% of the time. Due to this calcula-
tion method of dynamically adapting threshold values, a sudden increase in power 
density in an EEG frequency band instantly leads to suprathreshold values and thus 
immediately to an increase in the “inhibits” component.
To calculate for the “Signal” component the EEG power density of a “infra-slow” 
frequency band was extracted and determined. In the neurofeedback protocol used 
“infra-slow” frequencies are defined as frequencies below 0.1 Hz. Accordingly, the 
therapist is required to set the cut-off frequency of a low-pass filter in the mil-
lihertz frequency range via the software in order to extract the “infra-slow” “signal” 
component from the EEG and to continuously determine its signal strength.
One of the core features of the ILF neurofeedback is the subsequent transforma-
tion of the continuously determined “inhibit” as well as “signal” components into 
animated audio-visual feedback signals, which are presented to the patient on a 
separate computer screen. Typically, this is done via an animated computer game 
in which certain acoustic and visual parameters are directly coupled to either the 
“inhibit” or “signal” component or their ratio. Various feedback “games” were avail-
able to the ADHD patients for free selection and their common feature was that the 
calculated “inhibit” component modulated the volume of the underlying music and 
determined the color contrast and brightness of the animated environment. The 
simultaneous modulatory effects of the “Signal” component concerned the speed of 
the animated game character and the volume of its sounds.
Figure 2. 
Study design showing the different phases.
7
Therapeutic Effect of Infra-Low-Frequency Neurofeedback Training on Children…
DOI: http://dx.doi.org/10.5772/intechopen.97938
The promotion of CNS stability is the first objective of brain training [37]. Because 
brain stability is an individual feature, an individualized training strategy, in which 
the reinforcement “infra-slow” frequency is optimized for each individual, is a man-
datory element of the ILF neurofeedback protocol [55]. According to the protocol, the 
“signal” frequency has to be adjusted by the therapist during the first sessions to the 
state in which the person is maximally calm, attentive and as euthymic as the nervous 
system is capable of being at that moment. The fine-tuning of the optimal reinforce-
ment frequency (ORF) then is done on the basis of reports from the patient on their 
own status or observations of the therapist. In this study, the ORF for the infra-low 
signal was determined individually during the first 1–3 sessions based on the report 
of the patient or from observing behavioral signs of stress, alertness, wellbeing or 
relaxation on the patient by the therapist. Thereafter, the ILF neurofeedback therapy 
was proceeded with the “signal” frequency set to the patient’s individual ORF.
2.6 Continuous performance test (CPT)
In order to measure changes in attention, sustained attention and impulse 
control, a CPT with the QIKtest device (BEE Medic Inc., Germany) was carried out 
before the start and at the end of neurofeedback therapy. The QIKtest is a mobile, 
stand-alone test display/input device with a standardized test procedure that is 
used in particular to record selective attention, sustained attention and impulsive 
behavior. The CPT of the QIKtests consist of displaying “GO/NO GO “tasks for 21 
minutes. The test is divided into five phases, in which the occurrence, incidence 
and intervals of “GO” tasks differ to measure four parameters of attention: average 
reaction time (RT), variability of reaction time (VAR), omission errors (OM) and 
commission errors (CO).
During the CPT, two simple visual conditions (“target”/“GO” and “non-
target”/“NOGO”) are presented once every two seconds to the patients on the 
screen of the QIKtest device via nine luminous fields: “GO” when all fields except 
the middle field light up and “NO-GO” when all nine fields light up.
In a period of 2 seconds, in a seemingly (for the patient) random fashion one 
of the two stimulus conditions lights up for a duration of 100 milliseconds. The 
subject’s task is to press a button on the QIKtest device as quickly as possible only 
when the “GO” condition appears. This results in two possible types of errors: 
Omission errors, when the required reaction to the “GO” condition failed to appear, 
and commission errors, when the reaction button on the QIKtest device was pressed 
after a “NO-GO” signal was displayed. In addition, the QIKtest device measures the 
reaction time for each correct reaction with a measurement accuracy of 0.1 millisec-
onds and calculates RT and VAR.
The statistical evaluation of the test results was carried out using PSPP (GNU 
project, open source), version 1.2.0.
In order to qualitatively classify changes in the investigated attention param-
eters and those of impulse control, the CPT database of EEG Expert (EEG Expert 
Limited, Ankara, Turkey) was used. The “equivalent mental age”, derived from 
the mean result of a reference group for the specific age, was determined for RT, 
VAR, OM and CO from the corresponding norm curves. The CPT database contains 
>50,000 records of individuals of both sexes aged 6–70 years in 40 age groups, with 
at least 500 records per age group.
2.7 Symptom tracking
To assess symptom changes through ILF neurofeedback therapy, patients were 
asked to track their individual symptoms out of a catalog of 137 ADHD-specific 
and other symptoms from the categories of sleep, attention and learning behavior, 
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sensory and perception, behavior, emotions, physical symptoms and pain, before 
(T0) and after the ILF neurofeedback intervention (T2). Between the two points of 
measurement (T0 = Pre and T2 = post) was the phase of neurofeedback intervention 
(T1) (see Figure 2). Participating patients could indicate a severity level between 
0 (symptom does not apply at all) and 10 (symptom occurs very frequently or is 
maximal pronounced) for each of the 137 given symptoms.
The statistical evaluation of the symptom survey was done using the software 
PSPP, version 1.2.0.
3. Results
Of the 251 ADHD patients treated with ILF neurofeedback during the entire 
data collection period, only 196 had pre-post QIKtest data collected. The average 
duration of therapy in terms of neurofeedback sessions was 38.5 (SD = 21.6), three 
participants dropped out of therapy.
3.1 Continuous performance test
The pre-post data at T0 and T2 of 196 participants were included in the evalu-
ation of the continuous performance test using the QIKtest device. Changes in 
four variables were analyzed: average reaction time (RT), variability of reaction 
time (VAR), omission errors (OM) and commission errors (CO). The averaged RT 
of the patients improved during the duration of the ILF neurofeedback training 
by about 21 ms - from 457 ms at T0 to 436 ms at T2 (see Table 1). In parallel, VAR 
improved as well by about 18 ms - from 122 ms at T0 to 104 ms at T2. To examine 
their statistical significance, the values of RT and VAR were compared separately 
using independent Student’s t-tests, as a normal distribution with equal variances 
was given. According to the t-test results, the improvements of RT and VAR after 
ILF neurofeedback treatment were statistically highly significant (see Table 1). The 
third attention parameter that was measured, OM, too improved from an average 
of 9.6 errors (SD = 15.1 errors) at T0 to 5.0 errors (SD = 9.3 errors) at T2. The test 
parameter that determines impulse control CO improved from 19.1 errors (SD = 17.3 
errors) on average at T0 to 9.0 errors (SD = 9.0 errors) at T2. The significance of the 
improvements was examined statistically using a non-parametric Wilcoxon signed-
rank test, because OM and CO did not follow a normal distribution. According to 
their Wilcoxon signed rank test results, the improvements of OM and CO after ILF 
neurofeedback treatment were statistically highly significant (see Table 1).
To investigate the relevance (“quality”) of the improvements in the studied 
parameters of attention and impulse control in relation to mental maturity, the 
respective “equivalent mental age” for RT, VAR, OM and CO was determined from 
N = 196 Pre (T0) Post (T2) Difference p
Reaction Time (RT) 457 ± 88 ms 436 ± 85 ms −21 ms <0.00011
Variability of RT (VAR) 122 ± 31 ms 104 ± 30 ms −18 ms <0.00011
Omission Errors (OM) 9.6 ± 15.1 5.0 ± 9.3 −4.6 <0.00012
Commission Errors (CO) 19.1 ± 17.2 9.0 ± 9.0 −10.1 <0.00012
1Student’s t-test.
2Wilcoxon signed rank test.
Table 1. 
Results of the continuous performance test.
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the corresponding norm curves of the CPT database. On average, the participating 
ADHD patients had an age of 12.1 years. However, their averaged performance in 
the CPT before the start of the ILF neurofeedback training was clearly below their 
averaged actual age when compared with the CPT database (see Figure 3): the 
averaged performances for the attention parameters RT, VAR and OM of the average 
12.1-year-old ADHD patients corresponded to the 10.2 (RT), 10.0 (VAR) and 8.9 
(OM) years age groups in the CPT database and thus, lack a mental maturity of 
around 2 years. For the tested parameter of impulse control, CO, the averaged per-
formances of the ADHD patients corresponded to the 8.5 (CO) years age group in 
the CPT database and thus, showed an even slightly more delayed mental maturity 
of about 3.5 years.
In terms of “equivalent mental age” that was derived from the CPT database, 
the ADHD patients benefited considerably from the therapy. After the ILF neuro-
feedback training equivalent mental age of the ADHD patients clearly increased 
for RT from 10.2 to 12.3 years, for VAR from 10.0 to 12.8 years, for OM from 8.9 to 
10.3 years and for CO from 8.5 to 15.0 years (see Figure 3).
3.2 Symptom tracking
According to the patients’ self-disclosure or evaluation by the therapists, 97% of 
the patients experienced an improvement of the symptoms which had been indi-
vidually perceived as stressful before the neurofeedback therapy, like inattention, 
hyperactivity, impulsivity, difficulties to fall asleep, distractibility, rage and others. 
Only 3% of the patients claimed no noticeable improvement of the symptoms.
The course of symptom severity before, during and after approximately 30 
sessions of ILF neurofeedback was assessed in 43 ADHD patients for the three core 
symptoms of their disorder: inattention, hyperactivity and impulsivity. Before the 
start of the ILF neurofeedback intervention at T0 the patients evaluated the core 
symptoms of their disorder as to be very pronounced, with high average values for 
inattention, hyperactivity and impulsivity (see Table 2).
Comparison of these averaged severity values with the individually evaluated 
severity levels of these symptoms after the treatment with ILF neurofeedback at T2 
and determination of the level of significance by Wilcoxon signed rank test, all three 
core symptoms had been improved significantly. For the symptom of inattention, the 
participants reported at T2 a highly significant decrease of the individually perceived 
severity by 2.9, for hyperactivity by 3.5 and impulsivity by 1.3 (see Figure 4).
Figure 3. 




Since the first reports of successful neurofeedback treatment in ADHD 
[56], several studies have investigated the effects on symptoms of ADHD such 
as inattention, impulsivity and hyperactivity with neurofeedback protocols 
that utilize brain activity of conventional frequencies in the EEG. Such reports 
include those which facilitated the sensorimotor EEG rhythm (SMR) and 
inhibited beta rhythmicity and those which facilitated beta EEG rhythm and 
inhibited theta rhythmicity [40, 42, 57–60]. Another neurofeedback approach 
that is assumed to regulate cortical excitability and is used with positive results 
in the treatment of ADHD is training of Slow Cortical Potentials (SCP) [48, 61]. 
However, in this study Infra-low Frequency (ILF) neurofeedback was used, 
a modern, relatively new and effective neurofeedback treatment method for 
mental disorders. It utilizes both, brain activity of conventional frequencies in 
the human EEG (1–40 Hz) as well as activities in the frequency range of slow 
cortical potentials below 0.1 Hz. Other characteristics of the ILF neurofeedback 
protocol include a bipolar montage of the electrodes, placement of the elec-
trodes on the skull according to individual criteria of the patient’s arousal level 
and mental strength, and continuous feedback of the parameters extracted from 
the full-band EEG in audio-visual computer animations that have a game-like 
character.
Figure 4. 
Improvements in ADHD symptom ratings.
Symptom Time Severity of Symptoms p
Inattention T2 5.4 ± 2.2 0
*
T0 8.3 ± 1.4
Hyperactivity T2 4.6 ± 2.5 0.012
*
T0 8.1 ± 1.2




Severity of the different ADHD symptoms (statistics by Wilcoxon signed rank test).*= statistical significance 
attained.
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Recent reports demonstrate that ILF neurofeedback not only utilizes slow brain 
activity in the EEG but also can directly lead to a significant increase in spectral 
power in the sub 0.5 Hz frequency band [51, 52]. Clinically, it has been shown that 
children with attention deficits show smaller negative SCPs during the anticipation 
phase of a task in comparison to children without attention problems [16] or other 
EEG abnormalities in the frequency range of SCPs [46, 47]. In the light of these 
findings, we conducted this multi-center study to address the question of whether 
ILF neurofeedback is an effective and significant treatment for ADHD and leads to 
an improvement in quality of life of those affected.
A total of 251 ADHD child and adolescent patients were included in this study 
and received a treatment consisting of an average of 39 ILF neurofeedback sessions 
over a period of at least 15 weeks (about two sessions of neurofeedback per week). 
Only three patients decided to discontinue treatment prematurely. Although we did 
not investigate this aspect scientifically, it can be concluded from the low dropout 
rate that the ILF neurofeedback was well accepted as a treatment method by the 
vast majority of the ADHD patients (and their parents). According to the patients’ 
self-disclosure or evaluation by the therapists, 97% of the patients reported an 
improvement of the symptoms which had been individually perceived as stressful 
before the neurofeedback therapy. Only 3% of the patients claimed no noticeable 
improvement of the symptoms by the ILF neurofeedback training. The general 
effect of the ILF neurofeedback treatment therefore can be rated as excellent.
In order to make the patients’ subjective assessment of their symptoms measur-
able, they were asked before and after the end of treatment to perform an evalu-
ation of their most prominent symptoms on the basis of severity levels between 0 
and 10. The most severe symptoms were chosen from a questionnaire of 137 ADHD-
specific and other symptoms. This included the categories sleep, attention and 
learning behavior, sensory and perception, behavior, emotions, physical symptoms 
and pain. Regarding symptom tracking, complete data sets were unfortunately 
only available from 43 patients (and thus only from about 1/6 of the participating 
children and adolescents). Nevertheless, the size of this sample is sufficient for a 
statistical analysis in which we focused on the three core symptoms of the ADH 
disorder, inattention, hyperactivity and impulsivity. Before the ILF neurofeedback 
intervention, the severity of inattention was rated to be at 8.3 in average and thus, 
experienced as to be very pronounced. A similar average severity level was reported 
by the participants for the symptom of hyperactivity, which was 8.1. The impulsiv-
ity was rated at 7.4 on average and thus, only slightly less severe than the aforemen-
tioned symptoms. This shows that the three core symptoms of ADH disorder are 
indeed perceived by the patients as highly burdening. After the therapy of approx. 
30 sessions of ILF neurofeedback, the patients assessed these symptoms as signifi-
cantly less stressful, with a clear average improvement in inattention by 1.9 severity 
points and in hyperactivity by as much as 3.5 severity points. Regarding the severity 
of their impulsivity, the participating children and adolescents rated slight but 
significant decrease of 1.3 severity points after the treatment. From these results, it 
can be concluded that 30 sessions of ILF neurofeedback, according to the subjective 
perception of the patients, are sufficient to improve hyperactivity and inattention 
symptoms in children and adolescents with ADHD. The treatment can also lead to 
a slightly milder, but still significant improvement in impulsivity in the same group 
of patients. These effects of ILF neurofeedback therapy are in accordance with 
the results of controlled studies on ADHD using other neurofeedback protocols. 
In these studies high to moderate effect sizes were also found on inattention and 
impulsivity as well as on hyperactivity ([12, 13, 15, 62, 63], for a review see [64]).
These positive results are mainly based on the subjective sensations and 
experiences of ADHD patients. In order to examine and monitor the quality and 
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effectiveness of the ILF neurofeedback treatment on the basis of more objective 
criteria, the participants completed a 21-minute visual GO/NOGO continuous 
performance test (CPT) before the start and after the end of the intervention. 
Through this measure the parameters of attention and impulse control could be 
directly examined in detail. The three attention parameters that were tested are 
the response time, the variability of the response time and omission errors. The 
reaction or response time (RT) is the mean of all correct reaction times to a target 
stimulus (“GO” condition) and is a measure of the speed of responses. This atten-
tion parameter is accompanied by the variability of the response time (VAR), which 
is a measure of the consistency of the response. Finally, omission errors occur when 
the subject does not respond correctly to a target stimulus, which is assessed as a 
sign of inattention. A comparison of the test results prior and after about 15 weeks 
of ILF neurofeedback intervention revealed a significant improvement of all three 
attention parameters. The averaged Reaction time decreased for 21 ms, VAR for 
18 ms and the averaged OM by −4.6 errors. To transform these results into more 
tangible values, the conversion into an “equivalent mental age” (EMA) was done 
based on the large CPT database of EEG Expert. Here, the “equivalent mental age” 
indicates the specific age of the reference group whose norm test result corresponds 
with the test result of the patient.
The improvements in the three tested attention parameters are reflected in a 
significant increase in the EMA. Before the start of the ILF neurofeedback therapy 
the ADHD children and adolescents were about 2 years of EMA behind, but regard-
ing the attention parameters examined, they were able to make up for this delay 
within the 15 weeks of neurofeedback training. Most prominent was the improve-
ment in averaged consistency of the response time (VAR) which led to an increase 
of EMA by +2.8 years and the shorter mean response time (RT) which increased 
the EMA by +2.1 years. The improvement in omission errors was slightly less 
pronounced because it resulted to +1.4 years in equivalent mental age. For the three 
tested attention parameters it therefore can be stated that – within the 15 weeks 
period of ILF neurofeedback treatment - the brain of the ADHD patients had gained 
in maturation corresponding to a developmental progress of about two years.
Commission errors (CO) in the CP test occur when the patient responds (incor-
rectly) to a non-target (“NOGO”) task, which makes this test parameter a good 
measure for impulsivity. In all participating patients, impulse control improved 
significantly from an average of 19.1 CO errors before the ILF neurofeedback treat-
ment, to only 9.0 CO errors after the intervention. In terms of equivalent mental 
age, this means that the performance of the ADHD patients improved from a 
below-average of 8.5 years to an above-average EMA of 15.0 years after the EEG-
assisted neurofeedback intervention.
All objective improvements in the attention and impulsivity parameters 
examined in the CP testing are completely consistent with the ADHD patients’ 
subjectively perceived reductions in the severity of their symptoms of inattention, 
hyperactivity and impulsivity, which were rated as highly distressing prior to ILF 
neurofeedback treatment. Based on the data and feedback from clinicians and 
patients it therefore can be concluded that ILF neurofeedback can be seen as an 
effective method to treat ADHD in children and adolescents.
Due to the fact that ADHD on one hand is a complex psychiatric and neurologi-
cally based disorder which usually is associated with many comorbidities as social 
behaviors disorders, affective disorders, depression, anxiety, obsessive–compulsive 
disorders, bipolar disorders and others [1, 2] and ILF neurofeedback on the other 
hand is indicated for all of the mentioned ADHD comorbidities [65, 66]. It would 
therefore be interesting to undertake a more comprehensive evaluation of the 
symptom severities of ADHD patients and to investigate in a controlled study to 
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what extent ILF neurofeedback therapy leads to further improvements in cerebral 
self-regulation, which also encompasses the areas of other comorbidities of ADHD.
5. Conclusion
This observational clinical study could show significant improvements in major 
symptoms of ADHD - being inattention, hyperactivity and impulsivity - along 
with an improvement of attention, sustained attention and impulse control as 
well as the mental age equivalents in young patients with ADHD after ILF neuro-
feedback intervention. These results fit in line with presented study outcomes on 
neurofeedback in the treatment of ADHD - given the particularity that symptom 
based and individualized ILF neurofeedback presents a modern approach to EEG 
neurofeedback therapy options. Patients, parents and therapists evaluated the 
implementation and therapeutic outcome pleasant and positive. Whatsoever based 
on this and prior results it can be concluded that neurofeedback can be assessed as 
an effective, non-invasive, non-drug and pain-free treatment opportunity enlarg-
ing the ADHD treatment options. These promising results should motivate further 
research, especially studies overcoming the limitations of this one and including an 
interventional design, control parameters, further validated research instruments 
and long-term observations.
From a therapeutic point of view ILF neurofeedback can add a value to the 
treatment of children and adolescents with ADHD but further and more controlled 
research is needed to determinate outcome differences, especially in comparison to 
standard of care treatment.
© 2021 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
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